|Bid||0.00 x 1200|
|Ask||0.00 x 900|
|Day's range||220.99 - 225.00|
|52-week range||141.41 - 228.89|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||53.74|
|Earnings date||14 Feb 2022 - 18 Feb 2022|
|Forward dividend & yield||1.00 (0.45%)|
|Ex-dividend date||28 Oct 2021|
|1y target est||238.83|
PARSIPPANY, N.J., December 02, 2021--Zoetis has been named to Newsweek Magazine's America's Most Responsible Companies 2022 list.
Buying shares in the best businesses can build meaningful wealth for you and your family. And highest quality companies...
Johnson & Johnson (NYSE: JNJ) announced last week that it plans to spin off its consumer healthcare business into a separate publicly traded entity. J&J said that this move will unlock shareholder value and accelerate growth. Pfizer (NYSE: PFE) and GlaxoSmithKline established a joint venture for their consumer health units.